355 related articles for article (PubMed ID: 8012966)
61. SSTR3 is a putative target for the medical treatment of gonadotroph adenomas of the pituitary.
Lee M; Lupp A; Mendoza N; Martin N; Beschorner R; Honegger J; Schlegel J; Shively T; Pulz E; Schulz S; Roncaroli F; Pellegata NS
Endocr Relat Cancer; 2015 Feb; 22(1):111-9. PubMed ID: 25515731
[TBL] [Abstract][Full Text] [Related]
62. Somatostatin receptor 1 (SSTR1) and somatostatin receptor 5 (SSTR5)expression in hepatocellular carcinoma.
Koc EU; Ozgur T; Yerci O; Gurel S
Hepatogastroenterology; 2013 Oct; 60(127):1693-7. PubMed ID: 24634938
[TBL] [Abstract][Full Text] [Related]
63. Somatostatin receptor subtypes sst1, sst2, sst3 and sst5 expression in human pituitary, gastroentero-pancreatic and mammary tumors: comparison of mRNA analysis with receptor autoradiography.
Schaer JC; Waser B; Mengod G; Reubi JC
Int J Cancer; 1997 Mar; 70(5):530-7. PubMed ID: 9052751
[TBL] [Abstract][Full Text] [Related]
64. Somatostatin regulates tight junction function and composition in human keratinocytes.
Vockel M; Breitenbach U; Kreienkamp HJ; Brandner JM
Exp Dermatol; 2010 Oct; 19(10):888-94. PubMed ID: 20629740
[TBL] [Abstract][Full Text] [Related]
65. Expression of somatostatin receptors in normal, inflamed, and neoplastic human gastrointestinal tissues.
Reubi JC; Laissue J; Waser B; Horisberger U; Schaer JC
Ann N Y Acad Sci; 1994 Sep; 733():122-37. PubMed ID: 7978860
[TBL] [Abstract][Full Text] [Related]
66. Characterization of somatostatin receptors (SSTRs) expression and antiproliferative effect of somatostatin analogues in aggressive thyroid cancers.
Carmona Matos DM; Jang S; Hijaz B; Chang AW; Lloyd RV; Chen H; Jaskula-Sztul R
Surgery; 2019 Jan; 165(1):64-68. PubMed ID: 30415874
[TBL] [Abstract][Full Text] [Related]
67. Somatostatin receptor subtype gene expression in human and rodent tumors.
Eden PA; Taylor JE
Life Sci; 1993; 53(1):85-90. PubMed ID: 8515684
[TBL] [Abstract][Full Text] [Related]
68. Characterization of somatostatin receptor subtypes.
Bruns C; Weckbecker G; Raulf F; Lübbert H; Hoyer D
Ciba Found Symp; 1995; 190():89-101; discussion 101-10. PubMed ID: 7587655
[TBL] [Abstract][Full Text] [Related]
69. Selective activation of somatostatin receptor subtypes differentially modulates secretion and viability in human medullary thyroid carcinoma primary cultures: potential clinical perspectives.
Zatelli MC; Piccin D; Tagliati F; Bottoni A; Luchin A; Vignali C; Margutti A; Bondanelli M; Pansini GC; Pelizzo MR; Culler MD; Degli Uberti EC
J Clin Endocrinol Metab; 2006 Jun; 91(6):2218-24. PubMed ID: 16569735
[TBL] [Abstract][Full Text] [Related]
70. Gene expression of somatostatin receptor subtypes, SSTR1 and SSTR2, in human lung cancer cell lines.
Fujita T; Yamaji Y; Sato M; Murao K; Takahara J
Life Sci; 1994; 55(23):1797-806. PubMed ID: 7968260
[TBL] [Abstract][Full Text] [Related]
71. Analysis of somatostatin receptor subtype mRNA expression in human breast cancer.
Evans AA; Crook T; Laws SA; Gough AC; Royle GT; Primrose JN
Br J Cancer; 1997; 75(6):798-803. PubMed ID: 9062398
[TBL] [Abstract][Full Text] [Related]
72. Expression of somatostatin receptor subtypes (SSTR1-5) in Alzheimer's disease brain: an immunohistochemical analysis.
Kumar U
Neuroscience; 2005; 134(2):525-38. PubMed ID: 15961235
[TBL] [Abstract][Full Text] [Related]
73. Somatostatin receptor subtypes, octreotide scintigraphy, and clinical response to octreotide treatment in patients with neuroendocrine tumors.
Kölby L; Wängberg B; Ahlman H; Tisell LE; Fjälling M; Forssell-Aronsson E; Nilsson O
World J Surg; 1998 Jul; 22(7):679-83. PubMed ID: 9606281
[TBL] [Abstract][Full Text] [Related]
74. Somatostatin receptor (SSTR) expression and function in normal and leukaemic T-cells. Evidence for selective effects on adhesion to extracellular matrix components via SSTR2 and/or 3.
Talme T; Ivanoff J; Hägglund M; Van Neerven RJ; Ivanoff A; Sundqvist KG
Clin Exp Immunol; 2001 Jul; 125(1):71-9. PubMed ID: 11472428
[TBL] [Abstract][Full Text] [Related]
75. Differential regulation of somatostatin receptor types 1-5 in rat aorta after angioplasty.
Khare S; Kumar U; Sasi R; Puebla L; Calderon L; Lemstrom K; Hayry P; Patel AY
FASEB J; 1999 Feb; 13(2):387-94. PubMed ID: 9973327
[TBL] [Abstract][Full Text] [Related]
76. Dopamine 2 and somatostatin 1-5 receptors coexpression in clinically non-functioning pituitary adenomas.
Gabalec F; Drastikova M; Cesak T; Netuka D; Masopust V; Machac J; Marek J; Cap J; Beranek M
Physiol Res; 2015; 64(3):369-77. PubMed ID: 25536318
[TBL] [Abstract][Full Text] [Related]
77. Immunological detection of isoforms of the somatostatin receptor subtype, SSTR2.
Theveniau MA; Yasuda K; Bell GI; Reisine T
J Neurochem; 1994 Aug; 63(2):447-55. PubMed ID: 7518495
[TBL] [Abstract][Full Text] [Related]
78. Distribution and functional significance of somatostatin receptors in malignant melanoma.
Lum SS; Fletcher WS; O'Dorisio MS; Nance RW; Pommier RF; Caprara M
World J Surg; 2001 Apr; 25(4):407-12. PubMed ID: 11344389
[TBL] [Abstract][Full Text] [Related]
79. Localization of messenger ribonucleic acids for somatostatin receptor subtypes (sstr1-5) in the rat adrenal gland.
O'Carroll AM
J Histochem Cytochem; 2003 Jan; 51(1):55-60. PubMed ID: 12502754
[TBL] [Abstract][Full Text] [Related]
80. Somatostatin and dopamine receptor expression in neuroendocrine neoplasms: correlation of immunohistochemical findings with somatostatin receptor scintigraphy visual scores.
Diakatou E; Alexandraki KI; Tsolakis AV; Kontogeorgos G; Chatzellis E; Leonti A; Kaltsas GA
Clin Endocrinol (Oxf); 2015 Sep; 83(3):420-8. PubMed ID: 25808161
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
